Skip to content

News & Events

Clarivate Highly Cited Researchers 2025 list includes four NanoES faculty

David Cobden (physics), David Ginger (chemistry), Charles Marcus (materials science & engineering, physics), and Xiaodong Xu (physics, materials science & engineering) have been recognized for significant influence in their chosen field or fields of research through the publication of multiple papers in the top 1% of citations over the last decade.

Ayokunle Olanrewaju earns NIH Maximizing Investigators’ Research Award

NanoES faculty member Ayokunle Olanrewaju (bioengineering and mechanical engineering) has earned a Maximizing Investigators’ Research Award from the National Institutes of Health’s National Institute of General Medical Sciences. The $2.1 million grant is for five years. Often referred to as “R35 awards,” these grants support broad research programs over the course of several years, providing the nation’s most talented and promising researchers “greater stability…enhancing scientific productivity and the chances for important breakthroughs.”

Ultra-flat optic pushes beyond what was previously thought possible

In a first-of-its-kind achievement, a team of researchers at the University of Washington and Princeton University, co-led by NanoES faculty member Arka Majumdar (electrical & computer engineering, physics) and including NanoES director Karl Böhringer (ECE, bioengineering), has shown that a camera containing a large aperture, ultra-flat optic can record high-quality color images and video comparable to what can be captured with a conventional camera lens. The metalens, developed at the Washington Nanofabrication Facility (WNF), is hundreds of times smaller and thinner than a conventional camera lens, offering substantial savings in volume, weight, and device battery life.

New mRNA delivery system could transform cancer treatment

Researchers in the Miqin Zhang lab (materials science & engineering) have developed a promising new way to deliver messenger ribonucleic acid (mRNA) to cancer cells. Their novel polymer platform, a new nanoparticle comprised of perfluoroheptanoic acid (PFHA), polyethyleneimine (PEI), heparin (HP) and mRNA, shows enormous potential to outperform the current standard platform, lipid nanoparticles (LNPs).